Schizophrenia Trial, Recruiting NCT07055204 Sponsor: University Hospital, Toulouse Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07055204
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with schizophrenia or schizoaffective disorder according to standard diagnostic guidelines (DSM-5 TR criteria)
  • People who have been clinically stable, meaning no full-time hospital stay related to schizophrenia in the past 3 months
  • People who have regular appointments with a psychiatrist or mental health team
  • People who are already taking part in at least one structured therapeutic or social activity outside the home
  • People whose antipsychotic medication (type and dose) has not changed in the past 3 months
  • People who have given their free, fully informed, and written agreement to take part in the study
  • People who are covered by a social security or health insurance scheme

Who may not be able to join:

  • People with moderate to severe intellectual disability (as assessed by clinical criteria)
  • People who are already participating in a social rhythm or music-based activity
  • People who have a current addiction or substance use disorder, not including tobacco addiction or behavioural addictions (confirm with trial site)
  • People who have a neurological condition that affects thinking or memory
  • People who are currently enrolled in a brain training or neurocognitive rehabilitation program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05 61 43 78 63

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 September 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

attention capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov